Watchlist Price Alert

Opus Genetics Inc. (IRD)

NASDAQ: IRD · Real-Time Price · USD

0.99

-0.00 (-0.09%)

At close: Jun 12, 2025, 3:59 PM

1.00

1.32%

After-hours: Jun 12, 2025, 05:16 PM EDT

-0.09% (1D)

Bid	0.97
Market Cap	58.88M
Revenue (ttm)	10.99M
Net Income (ttm)	-57.53M
EPS (ttm)	-2.1
PE Ratio (ttm)	-0.47
Forward PE	-1.94
Analyst	Buy

Ask	1.01
Volume	191,117
Avg. Volume (20D)	916,053
Open	0.98
Previous Close	0.99
Day's Range	0.97 - 1.00
52-Week Range	0.65 - 2.18
Beta	0.29

About IRD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol IRD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IRD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 week ago

+9.6%

Opus Genetics shares are trading higher after the ... Unlock content with Pro Subscription

5 months ago

+18.93%

Opus Genetics shares are trading higher after the company announced it secured an FDA agreement under special protocol assessment for its Phase 3 trial of Oral APX3330 in diabetic retinopathy.

News

4 weeks ago · zacks.com

Opus Genetics, Inc. (IRD) Reports Q1 Loss, Tops Revenue Estimates

Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.29 per share a year ago.

1 month ago · zacks.com

Earnings Preview: Opus Genetics, Inc. (IRD) Q1 Earnings Expected to Decline

Opus Genetics, Inc. (IRD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.